Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
DNTH	DIANTHUS THERAPEUTICS INC	$6.16B	-22.50%	-21.50%	-16.31%	-29.60%	0.04	26.10	100.00%	-10,097.00%	-10,096.95%
HYPR	HYPERFINE INC	$90.78M	-100.30%	-63.30%	-64.15%	-225.70%	0.71	6.15	51.40%	-210.80%	-207.03%
PYPD	POLYPID LTD	$101.25M	-243.60%	-119.00%	-366.05%	-332.50%	1.83	1.35	N/A	N/A	N/A
ATR	APTARGROUP INC	$8.57B	13.60%	7.00%	12.95%	18.80%	0.95	1.61	36.10%	9.20%	13.16%
OPTH	OPTIMI HEALTH CORP	$28.51M	N/A	N/A	N/A	N/A	0.47	1.73	N/A	N/A	N/A
INO	INOVIO PHARMACEUTICALS INC	$129.25M	-1,005.80%	-111.10%	-711.67%	528.60%	10.30	1.00	N/A	N/A	N/A
GH	GUARDANT HEALTH INC	$21.90B	N/A	-25.50%	-28.58%	-21.10%	-9.58	4.03	65.00%	-38.30%	-38.01%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$563.21M	-53.90%	-48.20%	-25.65%	-97.90%	0.06	24.16	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$212.33M	-45.30%	-36.10%	-38.82%	-330.50%	0.22	9.03	89.90%	-153.60%	-147.80%
SDGR	SCHRODINGER INC	$1.40B	-16.40%	-8.20%	-11.13%	-14.70%	0.95	2.71	56.90%	-21.00%	-20.05%
MCRB	SERES THERAPEUTICS INC	$46.33M	-60.30%	-17.90%	-27.54%	-16.10%	1.94	2.11	100.00%	-1,192.90%	-1,192.94%
OM	OUTSET MEDICAL INC	$78.76M	-62.30%	-28.80%	-30.04%	-21.10%	1.52	5.19	41.80%	-63.10%	-50.62%
PALI	PALISADE BIO INC	$350.28M	-33.50%	-31.80%	-26.16%	956.50%	0.05	24.26	100.00%	-6,388.20%	-6,386.60%
DNA	GINKGO BIOWORKS HOLDINGS INC	$456.57M	-60.20%	-26.90%	-31.77%	-24.20%	1.36	4.57	77.70%	-260.00%	-260.49%
ACRS	ACLARIS THERAPEUTICS INC	$928.83M	-61.60%	-42.40%	-50.01%	-59.20%	0.44	3.46	12.90%	-921.50%	-921.50%
ACH	ACCENDRA HEALTH INC	$89.21M	N/A	-11.00%	-12.71%	-9.20%	-4.83	0.41	44.80%	-11.40%	-6.92%
FTH	FAETH THERAPEUTICS INC	$896.92M	-1,012.20%	-175.70%	-108.79%	-356.40%	0.06	19.69	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$249.44M	-26.40%	-20.20%	-24.88%	-29.00%	0.18	5.36	49.70%	-48.00%	-46.96%
NKTR	NEKTAR THERAPEUTICS	$2.52B	-38.00%	-25.80%	-12.31%	-22.10%	0.21	10.42	100.00%	-287.80%	-231.00%
CARL	CARLSMED INC	$431.38M	-38.10%	-29.00%	-33.09%	-67.30%	0.40	8.84	76.60%	-57.40%	-55.31%
BBIO	BRIDGEBIO PHARMA INC	$15.85B	N/A	-61.20%	-197.13%	-31.70%	-1.48	1.23	94.40%	-97.00%	-90.30%
DOCS	DOXIMITY INC	$4.51B	17.00%	14.50%	24.23%	31.70%	0.18	6.08	88.10%	25.50%	34.51%
GMRS	GMR SOLUTIONS INC	$715.25M	N/A	N/A	N/A	N/A	8.41	2.01	N/A	N/A	N/A
CBLL	CERIBELL INC	$918.77M	-44.90%	-35.70%	-43.03%	-41.60%	0.30	9.18	88.90%	-64.70%	-62.95%
DARE	DARE BIOSCIENCE INC	$12.25M	-748.10%	-38.70%	-201.69%	109.30%	-40.94	0.99	37.20%	-804.40%	-804.37%
INMB	INMUNE BIO INC	$65.50M	-82.90%	-62.20%	-87.88%	-1,798.40%	0.32	4.04	N/A	N/A	N/A
SOPH	SOPHIA GENETICS SA	$719.33M	-136.70%	-47.40%	-50.03%	-105.30%	1.39	2.69	66.60%	-93.90%	-85.50%
LFCR	LIFECORE BIOMEDICAL INC	$172.23M	N/A	-18.70%	-3.73%	-2.40%	-6.26	3.87	30.30%	-32.50%	-5.83%
RCKT	ROCKET PHARMACEUTICALS INC	$387.50M	-5.80%	-4.90%	-1.72%	-3.90%	0.15	9.25	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$123.16M	-65.50%	-62.90%	-75.08%	-77.10%	0.11	9.79	N/A	N/A	N/A
ADAG	ADAGENE INC	$261.86M	-32.20%	-20.50%	-19.21%	126.40%	0.31	5.02	100.00%	-220.80%	-221.64%
LTGO	LATIGO BIOTHERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.06	3.23	N/A	N/A	N/A
MANE	VERADERMICS INC	$4.11B	N/A	N/A	N/A	N/A	0.02	70.53	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$10.28B	-34.10%	-32.40%	-25.29%	-55.20%	0.04	15.73	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$4.24M	-639.50%	-85.10%	-57.91%	-47.90%	2.60	0.06	96.40%	-331.10%	-70.32%
CV	CAPSOVISION INC	$291.77M	-177.80%	-135.10%	-222.24%	-693.70%	0.41	3.35	50.90%	-214.70%	-214.56%
VRAX	VIRAX BIOLABS GROUP LTD	$1.74M	-75.70%	-68.10%	-76.73%	-333.40%	0.13	9.97	61.90%	-40,439.10%	-47,188.42%
CGC	CANOPY GROWTH CORP	$444.19M	-32.80%	-21.50%	-25.22%	-32.50%	0.60	3.04	25.20%	-80.40%	-80.49%
HROW	HARROW INC	$1.49B	-103.90%	-9.30%	-3.32%	-3.20%	26.45	2.24	73.30%	-13.50%	-3.79%
ROIV	ROIVANT SCIENCES LTD	$26.26B	-6.10%	-5.00%	-2.82%	-3.70%	0.09	16.72	81.20%	-3,535.00%	-1,879.06%
NVCT	NUVECTIS PHARMA INC	$777.72M	-184.30%	-105.20%	-306.61%	229.00%	1.46	1.68	N/A	N/A	N/A
SPRC	SCISPARC LTD	$2.43M	196.50%	135.60%	379.55%	686.20%	0.58	2.41	73.70%	1,422.80%	2,380.61%
VOGX	VOGENX INC	N/A	N/A	N/A	N/A	N/A	-1.64	0.39	N/A	N/A	N/A
PEPG	PEPGEN INC	$220.94M	-51.00%	-43.50%	-54.28%	-69.90%	0.18	13.36	N/A	N/A	N/A
GALT	GALECTIN THERAPEUTICS INC	$391.30M	N/A	-178.00%	14.69%	-34.60%	-1.10	0.10	N/A	N/A	N/A
JANX	JANUX THERAPEUTICS INC	$1.14B	-10.80%	-10.10%	-10.83%	-10.80%	0.09	16.35	100.00%	-427.50%	-427.47%
ONCO	ONCONETIX INC	$2.59M	-92.00%	-53.80%	-73.31%	145.60%	0.22	2.21	80.40%	-1,578.80%	-1,530.56%
NXTC	NEXTCURE INC	$26.96M	-175.50%	-113.70%	-263.76%	-252.10%	0.86	3.47	N/A	N/A	N/A
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$2.18B	N/A	N/A	N/A	N/A	0.03	35.85	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$8.03B	N/A	-172.90%	-159.13%	-62.70%	-1.60	5.72	99.30%	-598.60%	-529.60%
ABVX	ABIVAX SA	$9.17B	-98.60%	-69.80%	-44.05%	-1,055.50%	0.27	8.25	100.00%	-6,752.00%	-4,341.95%
DSGN	DESIGN THERAPEUTICS INC	$953.12M	-34.00%	-32.10%	-34.72%	-36.00%	0.07	18.86	N/A	N/A	N/A
ABSI	ABSCI CORP	$1.52B	-59.20%	-52.30%	-48.53%	-91.90%	0.09	10.63	100.00%	-7,756.40%	-7,750.35%
PBLS	PARABILIS MEDICINES INC	$4.75B	N/A	N/A	N/A	N/A	0.12	17.91	N/A	N/A	N/A
SLBT	SL SCIENCE HOLDING LTD	$1.52B	N/A	-5.30%	-162.64%	-5.40%	0.23	3.05	35.30%	-173.80%	-173.85%
IXHL	INCANNEX HEALTHCARE INC	$43.31M	-81.00%	-76.10%	-61.79%	-1,739.50%	0.07	41.57	N/A	N/A	N/A
GRAL	GRAIL INC	$3.42B	-15.90%	-14.00%	-19.18%	-65.20%	0.12	10.95	-31.30%	-236.90%	-320.38%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$4.08B	-32.60%	-11.90%	-9.47%	-10.60%	3.43	4.80	75.60%	-20.70%	-16.99%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.75B	-372.90%	-39.10%	-29.53%	-26.00%	45.60	6.77	95.80%	-87.50%	-70.71%
SCTX	SCRIBE THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.65	0.66	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.87B	-55.30%	-44.20%	-47.88%	-53.60%	0.39	8.37	97.40%	-14,191.20%	-14,188.37%
PROF	PROFOUND MEDICAL CORP	$248.42M	-63.00%	-51.20%	-62.28%	-188.00%	0.25	6.46	71.80%	-171.60%	-173.83%
DMRA	DAMORA THERAPEUTICS INC	$1.87B	-82.40%	-77.90%	-50.86%	1,686.80%	0.05	19.73	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$288.21M	-38.80%	-35.00%	-31.54%	408.90%	0.05	20.87	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$2.37B	-49.70%	-23.50%	-18.72%	-19.00%	1.93	8.37	88.20%	-88.20%	-72.49%
PLRZ	POLYRIZON LTD	$17.21M	-25.40%	-24.70%	-29.77%	-73.60%	0.02	29.03	N/A	N/A	N/A
BIAF	BIOAFFINITY TECHNOLOGIES INC	$3.14M	-257.30%	-159.50%	-306.46%	-1,731.40%	1.02	1.44	34.60%	-257.30%	-256.47%
LYEL	LYELL IMMUNOPHARMA INC	$361.21M	-91.60%	-70.50%	-91.59%	-93.70%	0.33	5.36	100.00%	-993,908.00%	-993,908.00%
CLYM	CLIMB BIO INC	$941.95M	-31.80%	-30.80%	-23.97%	-37.40%	0.03	31.45	N/A	N/A	N/A
CNTN	CANTON STRATEGIC HOLDINGS INC	$170.52M	-29.50%	-23.40%	-20.50%	-29.50%	0.24	15.70	100.00%	-6,559.30%	-7,700.14%
VOR	VOR BIOPHARMA INC	$1.34B	-91.60%	154.20%	137.60%	348.90%	-3.40	19.15	N/A	N/A	N/A
CODX	CO-DIAGNOSTICS INC	$7.63M	-211.00%	-175.00%	-354.60%	-1,161.40%	0.31	1.81	43.50%	-6,523.00%	-6,747.69%
MOBI	MOBIA MEDICAL INC	$365.54M	N/A	N/A	N/A	N/A	0.13	13.28	N/A	N/A	N/A
GNPX	GENPREX INC	$3.30M	-163.10%	-129.00%	-111.51%	4,732.10%	0.16	6.77	N/A	N/A	N/A
IMUX	IMMUNIC INC	$224.59M	-157.90%	-107.90%	-87.22%	412.10%	0.25	5.05	N/A	N/A	N/A
NUWE	NUWELLIS INC	$3.83M	-634.20%	-150.00%	-102.50%	-314.40%	-5.44	1.97	69.70%	-125.60%	-58.20%
CVM	CEL SCI CORP	$24.27M	-202.10%	-100.80%	-136.77%	-127.90%	0.95	1.48	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$436.64M	-34.80%	-34.10%	-26.04%	-39,873.30%	0.02	56.82	N/A	N/A	N/A
CRIS	CURIS INC	$3.30M	-1,035.30%	-87.90%	-399.49%	272.40%	3.04	0.49	99.70%	-490.30%	-490.33%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$857.63M	-77.70%	-68.00%	-40.48%	4,844.70%	0.08	14.20	75.00%	-4,619.30%	-4,589.16%
VANI	VIVANI MEDICAL INC	$124.48M	-191.10%	-70.90%	-75.22%	-84.50%	1.20	3.25	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$364.14M	-41.60%	-34.10%	-32.89%	-50.20%	0.21	6.61	100.00%	-28,468.00%	-28,587.29%
HYFT	MINDWALK HOLDINGS CORP	$64.46M	-85.80%	-50.20%	-92.94%	-127.10%	0.82	2.80	58.80%	-89.70%	-93.11%
GHRS	GH RESEARCH PLC	$1.93B	-20.90%	-20.10%	-17.24%	-220.00%	0.04	28.70	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$69.01M	-153.20%	-117.00%	-89.71%	-1,754.40%	0.20	4.27	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$175.82M	-89.10%	-62.50%	-83.30%	-67.60%	0.46	6.49	100.00%	-1,684.40%	-1,693.32%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.58B	-58.80%	-42.10%	-40.17%	-99.80%	0.38	4.41	51.40%	-138.40%	-130.11%
CAMP	CAMP4 THERAPEUTICS CORP	$271.09M	-314.10%	-106.40%	-144.37%	2,371.30%	-135.82	4.70	100.00%	-2,543.70%	-2,543.74%
IRD	OPUS GENETICS INC	$335.28M	N/A	-174.90%	-125.83%	-12,171.30%	-8.16	12.19	100.00%	-1,091.80%	-1,089.81%
ZCMD	ZHONGCHAO INC	$38.65k	-32.00%	-25.20%	-27.69%	-40.30%	0.08	11.11	45.00%	-55.50%	-55.07%
ACET	ADICET BIO INC	$83.32M	-74.90%	-60.90%	-75.87%	-82.00%	0.23	6.71	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.21B	-38.30%	-34.70%	-41.09%	-131.10%	0.12	9.03	100.00%	-3,644.20%	-3,644.21%
IRON	DISC MEDICINE INC	$3.11B	-37.20%	-33.70%	-34.34%	-38.20%	0.14	24.14	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$2.73B	-76.10%	-57.30%	-73.70%	-75.50%	0.33	6.34	100.00%	-928.40%	-929.18%
BCDA	BIOCARDIA INC	$16.05M	-569.40%	-183.20%	-271.81%	531.10%	0.76	2.09	N/A	N/A	N/A
CAI	CARIS LIFE SCIENCES INC	$7.38B	18.80%	9.30%	14.63%	25.90%	1.08	5.53	69.70%	10.60%	15.35%
SPTX	SEAPORT THERAPEUTICS INC	$1.29B	N/A	N/A	N/A	N/A	0.05	18.00	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$625.64M	-24.70%	-23.50%	-23.60%	-27.90%	0.05	37.17	N/A	N/A	N/A
ALMS	ALUMIS INC	$2.98B	-103.00%	-82.30%	-90.98%	-113.90%	0.24	6.74	100.00%	-5,933.50%	-5,957.20%
EQ	EQUILLIUM INC	$139.50M	-41.20%	-38.30%	-32.05%	2,525.80%	0.05	23.40	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	613	-0.66%	+1.64%	+7.19%	-17.98%	18.56x	5.57x	-15.13%	-10.95%	-8.57%	+46.54%	Strong Buy
Diagnostics & Research	50	-0.34%	+3.55%	+10.09%	+23.82%	14.40x	4.48x	-25.43%	+5.42%	+11.81%	+0.98%	Buy
Drug Manufacturers - General	20	-0.08%	+5.31%	+6.39%	+49.25%	40.91x	8.31x	+25.85%	+10.89%	+19.30%	+4.98%	Buy
Drug Manufacturers - Specialty & Generic	75	+0.18%	+0.39%	-1.16%	-93.84%	2.74x	1.67x	+2.45%	+3.59%	+20.64%	+40.41%	Strong Buy
Healthcare Plans	10	+1.15%	+1.07%	-1.15%	+22.84%	52.50x	2.37x	+10.84%	+3.32%	+8.21%	+10.47%	Buy
Health Information Services	50	-0.41%	+4.15%	+20.60%	-37.95%	10.43x	3.87x	+6.24%	+3.17%	+8.22%	+15.34%	Buy
Medical Care Facilities	48	-0.30%	+1.85%	+3.39%	+7.12%	17.17x	5.62x	-40.58%	+6.94%	+13.63%	+10.69%	Buy
Medical Devices	133	-0.80%	+0.62%	+9.31%	-99.46%	24.64x	3.37x	-4.67%	+5.19%	+9.51%	+21.95%	Strong Buy
Medical Distribution	9	+1.63%	+1.42%	+3.44%	+27.84%	25.42x	-176.85x	-71.67%	+4.08%	+24.10%	+13.05%	Buy
Medical Instruments & Supplies	52	-0.44%	+2.13%	+13.77%	+5.01%	44.70x	3.35x	+7.77%	+6.59%	+10.29%	+12.67%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bristol Myers Squibb Co (NYSE:BMY)

Bristol Myers Squibb Co (NYSE:BMY) is the #1 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bristol Myers Squibb Co (NYSE:BMY) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Bristol Myers Squibb Co (NYSE:BMY) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Bristol Myers Squibb Co has seen its stock return 42.72% over the past year, overperforming other healthcare stocks by 138 percentage points.

Bristol Myers Squibb Co has an average 1 year price target of $67.40, an upside of 0.18% from Bristol Myers Squibb Co's current stock price of $67.28.

Bristol Myers Squibb Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Bristol Myers Squibb Co, 54.55% have issued a Strong Buy rating, 0% have issued a Buy, 45.45% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #2 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 52, which is 26 points higher than the healthcare sector average of 26. It passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 82.77% over the past year, overperforming other healthcare stocks by 178 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -34.21% from Puma Biotechnology's current stock price of $9.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1060 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 49, which is 23 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 99.46% over the past year, overperforming other healthcare stocks by 195 percentage points.

Electromed has an average 1 year price target of $40.00, a downside of -0.72% from Electromed's current stock price of $40.29.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 78 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 38.27%, which is 36 percentage points higher than the healthcare sector average of 2.62%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 20.41%, which is 18 percentage points higher than the healthcare sector average of 2.62%.

Siga Technologies's dividend payout ratio of -1,500% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.75%, which is 9 percentage points higher than the healthcare sector average of 2.62%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.34% in the last day, and up 2.19% over the last week. Regenxbio was the among the top losers in the healthcare sector, dropping -24.86% yesterday.

REGENXBIO shares are trading lower after the company announced that the FDA placed a clinical hold on RGX-121 following the discovery of asymptomatic spine MRI findings in five participants in the CAMPSIITE study

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 71, which is 57 points higher than the healthcare sector average of 14. It passed 5 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 225.2% in the past year. It has overperformed other stocks in the healthcare sector by 320 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 43 points higher than the healthcare sector average of 14. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.89% in the past year. It has overperformed other stocks in the healthcare sector by 98 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 29, which is 15 points higher than the healthcare sector average of 14. It passed 2 out of 7 valuation due diligence checks.

Exelixis's stock has gained 43.93% in the past year. It has overperformed other stocks in the healthcare sector by 139 percentage points.

Are healthcare stocks a good buy now?

61.34% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 24.13% over the next year.

4.84% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.15% of healthcare stocks are rated B (Buy), 46.28% are rated C (Hold), 28.29% are rated D (Sell), and 7.44% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 31.74x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bristol Myers Squibb Co (NYSE:BMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Electromed (NYSEMKT:ELMD)

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

2. Siga Technologies (NASDAQ:SIGA)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bristol Myers Squibb Co (NYSE:BMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Electromed (NYSEMKT:ELMD)

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

2. Siga Technologies (NASDAQ:SIGA)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.